Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$367,388
-$58,276 QoQ
Shares Held
15,257
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,970
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCI Wealth Advisors, Inc. holds $24,505,177 across 8 Drug Manufacturers - General names. PFE ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,577 | $9,797,400 | |
| 2 | LLY |
ELI LILLY & Co
|
6,824 | $8,184,911 | |
| 3 | ABBV |
AbbVie Inc.
|
15,431 | $3,883,056 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,242 | $1,187,597 | |
| 5 | AMGN |
Amgen Inc
|
1,691 | $612,344 | |
| 6 | PFE |
Pfizer Inc
This page
|
15,257 | $367,388 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,558 | $262,631 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,661 | $209,850 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $367,388 | 15,257 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $425,664 | 15,159 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $395,312 | 15,876 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $405,386 | 15,910 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $427,836 | 17,650 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $473,655 | 18,692 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $522,800 | 19,706 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $439,888 | 15,200 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $409,347 | 14,630 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $383,643 | 13,825 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $438,385 | 15,227 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $482,457 | 14,545 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $619,011 | 16,876 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $687,398 | 16,848 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,072,453 | 20,930 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $898,611 | 20,535 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,080,110 | 20,601 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $986,839 | 19,062 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,036,268 | 17,549 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $826,394 | 19,214 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $698,066 | 17,826 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $717,680 | 19,809 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $744,224 | 20,218 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $2,414,527 | 65,791 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,190,738 | 66,995 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,175,648 | 66,656 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||